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Endograft repair of partially anomalous pulmonary
venous connection with dual drainage
Bora Peynircioglu, MD,a David M. Williams, MD,a Melvyn Rubenfire, MD,b Narasimham Dasika, MD,a
Gilbert R. Upchurch, Jr, MD,c and G. Michael Deeb, MD,d Ann Arbor, Mich
A 73-year-old woman with dyspnea and fatigue was found to have a partially anomalous pulmonary venous connection
with communication between the right upper lobe pulmonary vein and the superior vena cava, as well as a normal
pulmonary vein confluence with the left atrium. She was successfully treated with an endograft implanted in the superior
vena cava, covering the defect. The unique dual drainage of the pulmonary vein allowed percutaneous treatment of a
condition that ordinarily requires complex caval and intracardiac reconstruction. Except for several episodes of
arrhythmias, she has been doing well, with exercise tolerance improving from New York Heart Association class III at
baseline to class I after treatment. Follow-up imaging and clinical findings at 36 months showed no migration of the
stents and significant improvement of quality of life. ( J Vasc Surg 2005;42:1221–5.)A partially anomalous pulmonary venous connection
(PAPVC) is a congenital anomaly in which some, but not
all, of the pulmonary veins connect to the right atrium or to
one or more of its venous tributaries.1 The prevalence of
PAPVC is reported to be as high as 0.7% in autopsy series
and 10% in patients with an atrial septal defect.1,2
When it is associated with an atrial septal defect and a
hemodynamically significant left-to-right shunt, PAPVC
has traditionally required surgical correction with a twofold
goal: exclude the left-to-right shunt and reroute the anom-
alous pulmonary vein to the left atrium. When the anoma-
lous veins drain into the superior vena cava (SVC), surgical
correction involves patch atriocavoplasty or a variation of
the Warden procedure (translocation of the upper SVC to
the right atrium appendage and placement of an intracar-
diac baffle to conduct the anomalous pulmonary vein drain-
age to a pre-existing or newly created atrial septal de-
fect).3-6 Surgical treatment of this condition in the elderly
entails increased risks due to cardiac and pulmonary comor-
bidities.7
CASE REPORT
A 73-year-old woman presented with a 1-year history of
gradually progressive shortness of breath and fatigue, which was
classified as New York Heart Association (NYHA) class III. Her
medical history included systemic hypertension, arthritis, irritable
bowel syndrome, a carotid endarterectomy, and paroxysmal atrial
fibrillation. There was no history of Raynaud’s phenomenon, use
of weight-control drugs, or other triggers of pulmonary hyperten-
sion. Thromboembolic disease and collagen vascular diseases were
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normal jugular venous pulse, a right ventricular lift, a palpable S2,
and an audible increase in S2P.
A chest computed tomography (CT) scan early in her presen-
tation was normal except for increased size of pulmonary arteries
and increased right-sided heart dimensions. Chest radiography
showed minimal blunting of left posterior costophrenic angle. A
12-lead electrocardiogram (ECG) showed normal sinus rhythm
with occasional premature atrial complexes, RSR= in V1 and non-
specific ST and T wave abnormalities. Pulmonary function test
results were normal.
An echo-Doppler scan showed thickened mitral valve with
moderate mitral regurgitation, moderate tricuspid regurgitation,
an estimated right ventricular systolic pressure of 61 mm Hg,
mild-to-moderate pulmonic insufficiency, right atrial and ventric-
ular enlargement with good function, and no evidence of an
intracardiac shunt with agitated saline. A transesophageal echo-
Doppler scan demonstrated similar findings with no evidence of
shunting or anomalies.
The initial clinical impression was primary pulmonary hyper-
tension. She underwent right and left heart catheterizations. Mea-
surements of right-sided pressures and oxygen-saturation sampling
(Table) demonstrated a left-to-right shunt in the lower SVC with
a pulmonary-to-systemic flow ratio of 2.2 and very mild pulmonary
hypertension. There was a 60% stenosis of the proximal anterior
descending coronary artery. A PAPVC was suspected.
A magnetic resonance angiogram was limited by atrial prema-
ture beats. An ECG-gated CT angiogram demonstrated the right
upper lobe pulmonary vein communicating through a window-like
defect with the SVC and continuing to a normal confluence with
the left atrium (Fig 1). A pretreatment pulmonary angiogram
showed no acute or chronic pulmonary embolism. A selective right
upper lobe angiogram confirmed dual drainage into the SVC and
left atrium (Fig 2). An intravascular ultrasound scan showed that
the SVC defect was 23 mm in craniocaudal length and extended
from just below the azygos vein to 20 mm above the right atrium.
The SVC diameter was 20 mm above the defect and 23 mm below
it.
Description of the closure technique. Her symptoms were
considered likely due to the congenital anomaly because of the size
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considered a relatively high risk for surgical correction because of
her age, very mild pulmonary hypertension, and the history of
carotid and coronary atherosclerosis. However, the persistent com-
munication of the right upper lobe pulmonary vein with the left
atrium in this patient meant that the twofold goal of surgical
treatment, namely excluding the shunt and rerouting venous
drainage, could be met by means of an endograft covering the SVC
defect.
The ideal device would be a triple Z-ring endoprosthesis
consisting of a hook-bearing top uncovered Z-ring to seat within
the right innominate vein, connected to fully covered middle and
bottom Z-rings to cover the caval defect. At the time of this
procedure, the only commercially available devices were the aortic
cuffs used to supplement endovascular repair of abdominal aortic
aneurysms. We elected to use overlapping AneuRx cuffs (Medtronic,
Minneapolis, Minn) to cover the SVC defect and then secure the
endografts in place by bare Gianturco stents (Cook, Bloomington,
Ind) as needed.
Overlapping AneuRx aortic cuffs measuring 26 mm in diam-
eter  37.5 mm in length and 28 mm in diameter  37.5 mm in
length were deployed from the right internal jugular approach.
Each endograft was temporarily buttressed by the edge of an 11F
sheath inserted from the left femoral approach. To secure the
endografts within the venous system, which enlarged progres-
sively from the innominate vein to the right atrium, two 5-cm-
long Gianturco-Z stents were used to anchor the 26-mm en-
dograft to the right innominate vein and the 28-mm endograft
to the 26-mm endograft. After endograft and stent placement, a
right upper lobe pulmonary arteriogram and a left innominate
venogram showed closure of the SVC defect (Fig 3). Intravas-
cular ultrasound inspection of the right innominate vein and
SVC showed no component of the Z-stent protruding into the
lumen.
On the day after the endograft implantation, the patient
Measurements of right-sided cardiac pressures and
oxygen-saturation sampling
Pressure (mm Hg) Oxygen saturation (%)
IVC 71
SVC 60
CUFF 142/88
RA 4 88, 83, 67
(High, Mid, Low)
RV 33/4 85
PA 29/9 (mean 18) 82
PCWP 7
LV 146/11
FA 142/88 98
Calculated indices
Fick pulmonary flow 9.05 L/min
Fick systemic flow 4.07 L/min
PVR 1.2 Wood units
P/S ratio 2.2
IVC, Inferior vena cava; SVC, superior vena cava; RA, right atrium; RV,
right ventricle; PA, pulmonary artery; PCWP, pulmonary capillary wedge
pressure; LV, left ventricle; FA, femoral artery; PVR, pulmonary vascular
resistance; P/S ratio, pulmonary-to-systemic flow ratio.became bradycardic, with rates in the high 40s. The bradycardiaresolved spontaneously. Six months after the procedure, her exer-
cise tolerance improved substantially to NYHA class I.
She was treated with warfarin and aspirin. One year after the
procedure, she had a significant bleed into the rectus sheath, after
which the warfarin was stopped. She was continued on aspirin and
clopidogrel for paroxysmal atrial fibrillation.
Two years after the procedure she complained of difficulty
with balance, which resolved; however, a cerebellar infarct was
confirmed, thought likely embolic. Frequent symptomatic parox-
ysms of atrial fibrillation responded to amiodarone. The source of
the embolus was thought to be the left atrium, although it is
possible that it originated on the pulmonary side of the stent graft
covering the caval defect. She has had no clinical evidence for
pulmonary embolism or additional cerebrovascular events. Her
exercise tolerance remains normal for her age.
Follow up CT examinations at 1 and 2 years showed no
recurrence of the pulmonary vein-to-SVC communication, no
evidence of pulmonary emboli, and no migration of the endografts
or stents. Mild cardiomegaly, predominantly involving the right
atrium, and mild enlargement of the central pulmonary arteries
were unchanged from the preoperative examination.
DISCUSSION
PAPVC is frequently asymptomatic formany years. The
most important determinant for the severity of symptoms
and development of complications is the shunt fraction,
expressed as the ratio of pulmonary-to-systemic flow. In the
elderly, the physiologic sequelae of long-standing anoma-
lous pulmonary venous return to the right side of the heart
include right atrial and ventricular dilation and pulmonary
hypertension ranging frommild to occasionally severe. This
in turn may result in atrial arrhythmias and, uncommonly,
right-sided heart failure.
As noted earlier, the twofold goal of surgical correction
of PAPVC is to eliminate the left-to-right shunt and to
conduct the anomalous pulmonary venous drainage to the
left atrium. On the rare occasion of dual drainage, wherein
anomalous pulmonary-to-systemic venous communication
coexists with preserved left atrial drainage, one of these
goals is already met. The remaining challenge is to exclude
the shunt without jeopardizing existing left atrial return.
Forbess et al8 described two patients with dual drainage
of a pulmonary vein into a systemic vein and to the left
atrium who were treated by coil occlusion of the connec-
tion to the systemic vein. Such a procedure was not feasible
in the present instance because the cavopulmonary connec-
tion in this patient was a large window rather than a
channel-like vein.
PAPVC is known to be associated with cardiac arrhyth-
mias such as atrial tachycardia and atrial fibrillation. Fur-
thermore, surgical correction of PAPVC with connection
to the SVC is often complicated by sinus node dysfunction
and the need for a permanent pacemaker.9 Several factors
account for the high prevalence of sinus node dysfunction
in these patients. The sinoatrial node typically lies on the
lateral surface of the right atrial wall, near the junction with
the SVC. This region is typically the site of anomalous
lmon
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near the defect in the wall of the SVC itself.
In the typical surgical correction of this condition, the
lower SVC, containing the anomalous venous confluence,
Fig 1. Axial chest computed tomography images after
anomalous connection. B, Level of anomalous commu
communication in B. Upper and lower cuts (A andC) re
LA, Left atrium; A, aorta; PA, pulmonary artery; PV, puis modified by the insertion of a baffle to divert the pulmo-nary venous flow to an atrial septal defect, and the SA node
is at risk of traction injury or entrapment by a suture.
Intrinsic SA nodal abnormalities may be present as well. Tse
et al10,11 reported an unusual patient who failed several
venous contrast administration. A, Above the level of
ion. C, Level of right atrium. *Represents anomalous
normal superior vena cava, and pulmonary vasculature.
ary vein; SVC, superior vena cava.intra
nicat
vealedattempts at radiofrequency ablation in the SVC to termi-
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found to have an arrhythmic focus in an anomalous venous
connection between the left superior pulmonary vein and
SVC.
In the present patient, the SA node may have been near
the endograft used to exclude the cavopulmonary vein
communication. There are several potential mechanisms
for the transient sinus bradycardia that occurred on the day
after the procedure, including edema and inflammation in
the region of the sinus node directly or by stimulation of
vagal tone. In view of her history of atrial fibrillation, a
manifestation of a sick sinus syndrome is also possible.
Ischemia as a result of compression of terminal
branches of the sinus node artery was not a major concern.
Although the sinus node artery is a well described branch of
the right coronary artery passing through the sinus node
and occasionally originating as a separate branch from the
aorta or circumflex coronary artery, occlusion is not neces-
sarily accompanied by sinus node dysfunction, most likely
due to the Thebesian venous system in the right heart. This
is found predominantly in atria and is believed to provide an
additional route of myocardial drainage and offer an alter-
native route of nourishment to the myocardium via direct
connections with the arteries.12
CONCLUSION
PAPVC with caval communication, when associated
Fig 2. Pulmonary angiogram. Catheter (5F Head-Hunter cathe-
ter) courses from the superior vena cava (SVC) through the
fistulous communication into the right superior pulmonary vein.
Contrast injection shows normal drainage into the left atrium (LA)
as well as anomalous drainage into the SVC, confirming dual
drainage of right upper lung lobe. RA, right atrium; PV, pulmo-
nary vein.with a significant shunt ratio, usually requires complex cavaland cardiac reconstruction. In a small subgroup of patients
with anomalous venous communication but preserved left
atrial drainage (“dual drainage”), correction of the abnor-
mality is considerably simpler, and treatment may be feasi-
ble using percutaneous methods. We add to the literature
on dual drainage a description of a patient with window-
like communication between the right superior pulmonary
vein and the SVC who was successfully treated by percuta-
neous exclusion of this communication by means of an
endograft.
In this population with a high prevalence of sinus node
dysfunction, both surgical and percutaneous methods of
correcting PAPVC may be complicated by the onset of
atrial arrhythmias. Given available pacemaker technology,
Fig 3. Postoperative left innominate venogram shows venous
return to the heart without dilution from the right pulmonary vein.
RA, Right atrium; LIV, left innominate vein; SVC, superior vena
cava.sinus node dysfunction may be an acceptable trade-off for
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a sustained left-to-right shunt. We conclude that in patients
with PAPVC, one should search for dual drainage to allow
percutaneous treatment of this complex condition, espe-
cially in an elderly patient population with a high prevalence
of medical comorbidities.
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